Department of Spine Surgery, The Second People's Hospital of Changshu, The Affiliated Changshu Hospital of Xuzhou Medical University, Changshu, 215500, China.
Changshu Hospital Affiliated to Nanjing University of Traditional Chinese Medicine, Changshu, 215500, China.
Talanta. 2022 Feb 1;238(Pt 1):123001. doi: 10.1016/j.talanta.2021.123001. Epub 2021 Oct 28.
Detection of protein biomarkers relies largely on the development of modern immunological methods. Herein, a new enzyme-free immunological method is proposed to detect protein biomarkers. Employment of antibody-Cu(PO) hybrid nanoflowers, which are prepared through a facile and mild biomimetic-mineralizing process, is the core concept of the method. These nanoflowers can perform functions: one is to bind to target protein biomarkers with high specificity; the other is to release large amounts of Cu upon acid treatment, which can interact with creatinine and exert peroxidase-mimicking enzyme activity, therefore producing a distinctly amplified signal. Using osteocalcin, a well-known circulating protein biomarker for bone formation, as a model, the method affords a linear range from 0.1 to 50 ng/mL with a detection limit of 0.042 ng/mL, which is superior to reported methods. Moreover, the method shows considerable specificity, desirable performance in serum samples and eliminates the use of enzymes, so a great potential for this method is expected to meet the need of the clinical diagnosis.
蛋白质生物标志物的检测在很大程度上依赖于现代免疫学方法的发展。本文提出了一种新的无需酶的免疫学方法来检测蛋白质生物标志物。该方法的核心概念是利用通过简便温和的仿生矿化过程制备的抗体-Cu(PO) 杂化纳米花。这些纳米花可以发挥两个功能:一是与目标蛋白质生物标志物特异性结合;二是在酸性处理时释放大量的 Cu,Cu 可以与肌酸相互作用并发挥过氧化物酶模拟酶活性,从而产生明显放大的信号。以骨形成的已知循环蛋白质生物标志物骨钙素为模型,该方法提供了从 0.1 到 50ng/mL 的线性范围,检测限为 0.042ng/mL,优于已报道的方法。此外,该方法表现出相当的特异性、在血清样本中的良好性能且无需使用酶,因此该方法有望满足临床诊断的需求。